Free Trial

Pyxis Oncology (PYXS) Insider Trading & Ownership

Pyxis Oncology logo
$2.26 -0.04 (-1.74%)
Closing price 04:00 PM Eastern
Extended Trading
$2.21 -0.05 (-2.26%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pyxis Oncology (NASDAQ:PYXS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.60%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$232.65K
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$86.01K
Get PYXS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PYXS Insider Buying and Selling by Quarter

Pyxis Oncology Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/21/2025
Rachel Humphrey
Director
Sell13,896$1.03$14,312.88  
4/17/2025
Rachel Humphrey
Director
Sell200$0.97$194.00  
4/14/2025
Rachel Humphrey
Director
Sell1,400$0.97$1,358.00  
11/26/2024
Pamela Ann Connealy
CFO
Buy88,850$1.96$174,146.00  
9/27/2023
Jitendra Wadhane
CAO
Buy2,500$1.87$4,675.00  
9/27/2023
Pamela Ann Connealy
CFO
Buy6,426$1.85$11,888.10  
9/25/2023
Jitendra Wadhane
CAO
Buy5,000$1.77$8,850.00  
9/25/2023
Pamela Ann Connealy
CFO
Buy12,000$1.67$20,040.00  
9/22/2023
Jitendra Wadhane
CAO
Buy2,500$1.74$4,350.00  
9/22/2023
Pamela Ann Connealy
CFO
Buy5,000$1.74$8,700.00  
9/18/2023
Lara Sullivan
CEO
Sell8,541$2.10$17,936.10  
9/13/2023
Lara Sullivan
CEO
Sell3,000$2.27$6,810.00  
9/11/2023
Lara Sullivan
CEO
Sell20,000$2.27$45,400.00  
(Data available from 1/1/2013 forward)

PYXS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Pyxis Oncology includes Jitendra Wadhane, Lara Sullivan, Pamela Ann Connealy, and Rachel Humphrey. Learn more on insiders at PYXS.

10.60% of Pyxis Oncology stock is owned by insiders. Learn more on PYXS's insider holdings.

The following insider purchased PYXS shares in the last 24 months: Pamela Ann Connealy ($174,146.00).

Insiders have purchased a total of 88,850 PYXS shares in the last 24 months for a total of $174,146.00 bought.

The following insider sold PYXS shares in the last 24 months: Rachel Humphrey ($15,864.88).

Insiders have sold a total of 15,496 Pyxis Oncology shares in the last 24 months for a total of $15,864.88 sold.

Pyxis Oncology Active Insiders



This page (NASDAQ:PYXS) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners